BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36586187)

  • 1. Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cells.
    Iwanaga T; Chiba T; Nakamura M; Kaneko T; Ao J; Qiang N; Ma Y; Zhang J; Kogure T; Yumita S; Ishino T; Ogawa K; Kan M; Nakagawa M; Fujiwara K; Fujita N; Sakuma T; Kanzaki H; Koroki K; Kusakabe Y; Inoue M; Kobayashi K; Kanogawa N; Kiyono S; Kondo T; Nakagawa R; Ogasawara S; Nakamoto S; Muroyama R; Kato J; Kanda T; Maruyama H; Mimura N; Honda T; Murayama T; Nakamura H; Kato N
    Biochem Biophys Res Commun; 2023 Jan; 642():192-200. PubMed ID: 36586187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amygdalin Ameliorates Liver Fibrosis through Inhibiting Activation of TGF-β/Smad Signaling.
    Xiao Z; Ji Q; Fu YD; Gao SQ; Hu YH; Liu W; Chen GF; Mu YP; Chen JM; Liu P
    Chin J Integr Med; 2023 Apr; 29(4):316-324. PubMed ID: 34816365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
    Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
    Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice.
    Lu J; Zhang J; Wang Y; Sun Q
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
    Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
    World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
    Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
    Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aloin Attenuates Oxidative Stress, Inflammation, and CCl
    Bai J; Qian B; Cai T; Chen Y; Li T; Cheng Y; Wu Z; Liu C; Ye M; Du Y; Fu W
    J Agric Food Chem; 2023 Dec; 71(49):19475-19487. PubMed ID: 38038700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling.
    Chen C; Chen J; Wang Y; Fang L; Guo C; Sang T; Peng H; Zhao Q; Chen S; Lin X; Wang X
    Phytomedicine; 2023 Feb; 110():154626. PubMed ID: 36603342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-n-Butyl haloperidol iodide ameliorates liver fibrosis and hepatic stellate cell activation in mice.
    Shen DF; Cheng H; Cai BZ; Cai WF; Wang B; Zhu Q; Wu YB; Liu M; Chen RJ; Gao FF; Zhang YM; Niu YD; Shi GG
    Acta Pharmacol Sin; 2022 Jan; 43(1):133-145. PubMed ID: 33758354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
    Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY
    Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-
    Qiu JL; Zhang GF; Chai YN; Han XY; Zheng HT; Li XF; Duan F; Chen LY
    J Pharmacol Exp Ther; 2022 Jun; 381(3):257-265. PubMed ID: 35398813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Geniposide inhibits hepatic fibrosis and hepatic stellate cell activation through blocking the TGF-β1/Smad signaling pathway].
    Zhou LH; Chen X
    Sheng Li Xue Bao; 2022 Apr; 74(2):217-224. PubMed ID: 35503069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
    Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
    J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hydroxynitone suppresses hepatic stellate cell activation by inhibiting TGF-β1 phosphorylation to alleviate CCl
    Zhao Z; Dong H; Li B; Shen B; Guo Y; Gu T; Qu Y; Cai X; Lu L
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1511-1516. PubMed ID: 36329585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shugan Huoxue Huayu Fang attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting transforming growth factor-β1/Smad signaling.
    Liu L; Guo HB; Shao CP; Wang L; Xu YQ; Zhou YM
    J Tradit Chin Med; 2022 Feb; 42(1):65-72. PubMed ID: 35294124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limonin relieves TGF-β-induced hepatocyte EMT and hepatic stellate cell activation in vitro and CCl
    Shu G; Dai C; Yusuf A; Sun H; Deng X
    J Nutr Biochem; 2022 Sep; 107():109039. PubMed ID: 35533902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT1 activation ameliorates rhesus monkey liver fibrosis by inhibiting the TGF-β/smad signaling pathway.
    Xia Y; Luo Q; Gao Q; Huang C; Chen P; Zou Y; Chen X; Liu W; Chen Z
    Chem Biol Interact; 2024 May; 394():110979. PubMed ID: 38555046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.